LY-res-3

N/A

Report date: 2026/04/28 20:00:22

Base Information

Drug NameLY-res-3
Drug Alias NameN/A
ClassificationBiologics > Lysosome-Targeting Chimaeras (LYTAC)
Mechanisms of ActionSerotonin 2a (5-HT2a) receptor degradersAsialoglycoprotein receptor binders
TargetsSerotonin 2a (5-HT2a) receptorAsialoglycoprotein receptor
Therapy Area/IndicationsLiver Cirrhosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsLiver Cirrhosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A